Brain cysticercosis

Archives of Medical Research

Volumn 31, Issue 1, 2000, Pages 3-14

  Sotelo, Julio ^a   Del Brutto, Oscar H ^b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b HOSPITAL LUIS VERNAZA   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; DEXAMETHASONE; PRAZIQUANTEL; PREDNISONE;

BRAIN CYSTICERCOSIS; BRAIN INFARCTION; BRAIN SCINTISCANNING; EPILEPSY; HUMAN; INTRACRANIAL HYPERTENSION; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEIZURE; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK;

BRAIN DISEASES; CYSTICERCOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 0034594492     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(99)00073-9     Document Type: Review

References (124)

1. Del Brutto O.H., Sotelo J., Román G.C. Neurocysticercosis. a clinical handbook:1998;Swets & Zeitlinger, Lisse, The Netherlands.
2. Díaz F., García H.H., Gilman R.H.et al. Epidemiology of taeniasis and cysticercosis in a Peruvian village. Am J Epidemiol. 135:1992;875.
3. Botero D. Estudio sobre cisticercosis en Colombia. Rev UIS Med Bucar. 14:1986;19.
4. Dumas M., Grunitsky K., Belo M.et al. Cysticercose et neurocysticercose. enquete epide miologique dans le nord du Togo Bull Soc Path Exot. 83:1990;263.
5. Mignard C., Mignard D., Dandelot J.B.et al. Enquete epidemiologique sue l'endemie cysticerquienne a la Reunion. Rev Neurol (Paris). 142:1986;635.
6. Coker-Vann M.R., Subianto D.B., Brown P.et al. ELISA antibodies to cysticerci of Taenia solium in human population in New Guinea, Oceania, and Southeast Asia. Southeast Asian J Trop Med Public Health. 12:1981;499.
7. Loo L., Braude A. Cerebral cysticercosis in San Diego. a report of 23 cases and a review of the literature Medicine. 61:1982;341.
8. Richards F.O. Jr., Schantz P.M., Ruiz-Tiben E., Sorvillo F.J. Cysticercosis in Los Angeles County. JAMA. 254:1985;3444.
9. Shandera W.X., White C.A. Jr., Chen J.C., Díaz P., Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine. 73:1994;37.
10. Cuetter A.C., Guerra L.G., Meza A.D., Brower R.D. Neurocysticercosis. a special problem in the southwestern United States J Trop Geogr Neurol. 2:1992;172.
11. Schantz P.M., Moore A.C., Muñoz J.et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med. 327:1992;692.
12. Sarti E., Schantz P.M., Plancarte A.et al. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg. 46:1992;677.
13. Sarti E., Schantz P.M., Plancarte A.et al. Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan state, Mexico. Trans R Soc Trop Med Hyg. 88:1994;49.
14. Rabiela M.T., Rivas A., Flisser A. Morphological types of Taenia solium cysticerci. Parasitol Today. 5:1989;357.
15. Estañol B., Kleriga E., Loyo M.et al. Mechanisms of hydrocephalus in cerebral cysticercosis. implications for therapy Neurosurgery. 13:1983;119.
16. Del Brutto O.H. Cysticercosis and cerebrovascular disease. a review J Neurol Neurosurg Psychiatry. 55:1992;252.
17. Madrazo I., García-Rentería J.A., Sandoval M., López-Vega F.J. Intraventricular cysticercosis. Neurosurgery. 12:1983;148.
18. Akiguchi I., Fujiwara T., Matsuyama H., Muranaka H., Kameyama M. Intramedullary spinal cysticercosis. Neurology. 29:1979;1531.
19. Firemark H.M. Spinal cysticercosis. Arch Neurol. 35:1978;250.
20. Flisser A., Pérez-Montfort R., Larralde C. The immunology of human and animal cysticercosis. a review Bull World Health Organ. 57:1979;839.
21. Grogl M., Estrada J.J., McDonald G., Kuhn R.E. Antigen-antibody analyses in neurocysticercosis. J Parasitol. 71:1985;433.
22. Khan N.A., Sotelo J. Presentation of a membrane cysticercus antigen and its homology with excretory-secretory antigen. Acta Leidensia. 57:1989;123.
23. Flisser A., Woodhouse E., Larralde C. Human cysticercosis. antigens, antibodies and non-responders Clin Exp Immunol. 39:1980;27.
24. Flisser A. Taenia solium cysticercosis. some mechanisms of parasite survival in immunocompetent hosts Acta Leidensia. 57:1989;259.
25. Mandujano A., Vela M., Alcántara P., Correa D. Presence of a receptor for the Fc fraction of IgG in Taenia solium. Bull Soc Fr. 8(Suppl 1):1990;578. [Abstract].
26. Flisser A. Taeniasis and cysticercosis due to Taenia solium. Sun T. Progress in clinical parasitology. 1994;CRC Press, Boca Raton, FL. 77.p.
27. Ridaura-Sanz C. Host response in childhood neurocysticercosis. Childs Nerv Syst. 3:1987;206.
28. Del Brutto O.H., Castillo P.R., Mena I.X., Freire A.X. Neurocysticercosis among patients with cerebral gliomas. Arch Neurol. 54:1997;1125.
29. Schneider J., Hofman F.M., Apuzzo M.L.J., Hinton D.R. Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg. 77:1992;265.
30. Montero R., Flisser A., Madrazo I., Cuevas C., Ostrosky-Wegman P. Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. Mutat Res. 305:1994;181.
31. Del Brutto O.H., Sotelo J. Neurocysticercosis. an update Rev Infect Dis. 10:1988;1075.
32. McCormick G.F., Zee C.-S., Heiden J. Cysticercosis cerebri. a review of 127 cases Arch Neurol. 39:1982;540.
33. Sotelo J., Guerrero V., Rubio F. Neurocysticercosis. a new classification based on active and inactive forms Arch Intern Med. 145:1985;442.
34. Sotelo J. Cysticercosis. Vinken P.J., Bruyn G.W., Klawans H.L. Handbook of clinical neurology. Vol 52. 1988;Elsevier, Amsterdam. 529.p.
35. Barry M., Kaldjian L.C. Neurocysticercosis. Semin Neurol. 13:1993;131.
36. Arseni C., Cristescu A. Epilepsy due to cerebral cysticercosis. Epilepsia. 13:1972;253.
37. Del Brutto O.H., Santibáñez R., Noboa C.A., Aguirre R., Díaz E., Alarcón T.A. Epilepsy due to neurocysticercosis. analysis of 203 patients Neurology. 42:1992;389.
38. Arruda W.O. Etiology of epilepsy. a prospective study of 210 cases Arq Neuropsiquiatr. 49:1991;251.
39. García H.H., Gilman R., Martínez M.et al. Cysticercosis as a major cause of epilepsy in Peru. Lancet. 341:1993;197.
40. Medina M.T., Rosas E., Rubio-Donnadieu F., Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 150:1990;323.
41. Trelles L. Neurocysticercosis and epilepsy in Peru. Clin Neurol Neurosurg. 94(Suppl):1992;S153.
42. Goldsmith P., Sandmann M.C., Souza D.S., Mazer S., Antoniuk A., de Bittencourt P.R.M. The relationship between parasite location and electroclinical abnormality in neurocysticercosis. Neurol Infect Epidemiol. 11:1996;127.
43. Del Brutto O.H. Neurocysticercosis. Curr Opin Neurol. 10:1997;268.
44. Rodríguez-Carbajal J., Del Brutto O.H., Penagos P., Huebe J., Escobar A. Occlusion of the middle cerebral artery due to cysticercotic angiitis. Stroke. 20:1989;1095.
45. ter-Penning B., Litchman C., Heier L. Bilateral middle cerebral artery occlusions in neurocysticercosis. Stroke. 23:1992;280.
46. Monteiro L., Almeida-Pinto J., Leite I., Xavier J., Correia M. Cerebral cysticercus arteritis. five angiographic cases Cerebrovasc Dis. 4:1994;125.
47. Gauthier N., Sangla S., Stroh-Marcy A., Payen L. Neurocysticercose révélé par un accident vasculaire cérébral. J Radiol. 76:1995;119.
48. Levy A.S., Lillehei K.O., Rubinstein D., Stears J.C. Subarachnoid neurocysticercosis with occlusion of major intracranial arteries. case report Neurosurgery. 36:1995;183.
49. Del Brutto O.H. Infections and stroke. Ginsberg M., Bogousslavsky J. Cerebrovascular disease. Pathophysiology, diagnosis, and management. Vol II. 1998;Blackwell Science, Malden, MA, USA. 1628.p.
50. Forlenza O.V., Filho A.H.G.V., Nobrega J.P.S.et al. Psychiatric manifestations of neurocysticercosis. a study of 38 patients from a neurologic clinic in Brazil J Neurol Neurosurg Psychiatry. 62:1997;612.
51. Sotelo J., Del Brutto O.H., Román G.C. Cysticercosis. Remington J.S., Swartz M.N. Current clinical topics in infectious diseases. Vol 16. 1996;Blackwell Science, Cambridge, MA, USA. 240.p.
52. Milenkovic Z., Penev G., Stojanovic D., Jovicic V., Antovic P. Cysticercosis cerebri involving the lateral ventricle. Surg Neurol. 18:1982;94.
53. Jankowski R., Zimmerman R.D., Leeds N.E. Cysticercosis presenting as a mass lesion at foramen of Monro. J Comput Assist Tomogr. 3:1979;694.
54. Arellano-Sánchez J., Aruffo C., Escobar A. Cisticercosis del IV ventrículo y síndrome de Bruns. Rev Fac Med UNAM (Mex). 28:1985;11.
55. Rangel R., Torres B., Del Brutto O., Sotelo J. Cysticercotic encephalitis. A severe form in young females. Am J Trop Med Hyg. 36:1987;387.
56. Noboa C.A. Encefalitis cisticercosa. Rev Ecuat Neurol. 1:1992;61.
57. Del Brutto O.H., Sotelo J. Neurocysticercosis simulating pseudotumor cerebri (pseudopseudotumor). J Neuroophthalmol. 8:1988;87.
58. Del Brutto O.H., Guevara J., Sotelo J. Intrasellar cysticercosis. J Neurosurg. 69:1988;58.
59. Cabieses F., Vallenas M., Landa R. Cysticercosis of the dorsal spinal cord. J Neurosurg. 16:1959;337.
60. Venkataramana N.K., Jain V.K., Das B.S., Rao T.V. Intramedullary cysticercosis. Clin Neurol Neurosurg. 91:1989;337.
61. Kruger-Leite E., Jalkh A.E., Quiroz H., Schepens C.L. Intraocular cysticercosis. Am J Ophthalmol. 99:1985;252.
62. Cardenas F., Quiroz H., Plancarte A., Meza A., Dalma A., Flisser A. Taenia solium ocular cysticercosis. findings in 30 cases Ann Ophthalmol. 24:1992;25.
63. Lozano-Elizondo D. Ophthalmic cysticercosis. Palacios E., Rodríguez-Carbajal J., Taveras J.M. Cysticercosis of the central nervous system. 1983;Charles C Thomas, Springfield, MA, USA. 84.p.
64. Jolly S.S., Pallis C. Muscular pseudohypertrophy due to cysticercosis. J Neurol Sci. 12:1971;155.
65. Sawhney B.B., Chopra J.S., Banerji A.K., Wahi P.L. Pseudohypertrophic myopathy in cysticercosis. Neurology. 26:1976;270.
66. Del Brutto O.H. Cysticercosis. Feldmann E. Current diagnosis in neurology. 1994;Mosby, St. Louis, MO, USA. 125.p.
67. Mervis B., Lotz J.W. Computed tomography (CT) in parenchymatous cerebral cysticercosis. Clin Radiol. 31:1980;521.
68. Rodacki M.A., Detoni X.A., Teixeira W.R., Boer V.H., Oliveira G.C. CT features of Cellulosae and Racemosus neurocysticercosis. J Comput Assist Tomogr. 13:1989;1013.
69. Suss R.A., Maravilla K.R., Thompson J. MR imaging of intracranial cysticercosis. comparison with CT and anatomopathologic features Am J Neuroradiol. 7:1986;235.
70. Martínez H.R., Rangel-Guerra R., Elizondo G.et al. MR imaging in neurocysticercosis. a study of 56 cases Am J Neuroradiol. 10:1989;1011.
71. Rodríguez-Carbajal J., Salgado P., Gutiérrez-Alvarado R., Escobar-Izquierdo A., Aruffo C. The acute encephalitic phase of neurocysticercosis. computed tomographic manifestations Am J Neuroradiol. 4:1983;51.
72. Del Brutto O.H. Single parenchymal brain cysticercus in the acute encephalitic phase. definition of a distinct form of neurocysticercosis with benign prognosis J Neurol Neurosurg Psychiatry. 58:1995;247.
73. Chandy M.J., Rajshekhar V., Ghosh S.et al. Single small enhancing CT lesions in Indian patients with epilepsy. clinical, radiological and pathological considerations J Neurol Neurosurg Psychiatry. 54:1991;702.
74. Bandres J.C., White A.C. Jr., Samo T., Murphy E.C., Harris R.L. Extraparenchymal neurocysticercosis. report of five cases and review of management Clin Infect Dis. 15:1992;799.
75. Zee C.-S., Segall H.D., Apuzzo M.L.J., Ahmadi J., Dobkin W.R. Intraventricular cysticercal cysts. further neuroradiological observations and neurosurgical implications Am J Neuroradiol. 5:1984;727.
76. Ginier B.L., Poirier V. MR imaging of intraventricular cysticercosis. Am J Neuroradiol. 13:1992;1247.
77. Salgado P, Rojas R, Sotelo J. Cysticercosis: clinical classification based on imaging studies. Arch Intern Med 1997;157:1991.
78. Mahajan R.C., Chopra J.S., Ganguly N.K. Human cysticercosis and epilepsy. a serologic study Flisser A., Willms K., Laclette J.P., Larralde C., Ridaura C., Beltrán F. Cysticercosis. present state of knowledge and perspectives:1982;Academic Press, New York. 171.p.
79. Rosas N., Sotelo J., Nieto D. ELISA in the diagnosis of neurocysticercosis. Arch Neurol. 43:1986;353-356.
80. García E., Sotelo J. A new complement fixation test for the diagnosis of neurocysticercosis in cerebrospinal fluid. J Neurol. 238:1991;379.
81. Richards F. Jr., Schantz P.M. Laboratory diagnosis of cysticercosis. Clin Lab Med. 11:1991;1011.
82. Tsang V.C.W., Brand J., Boyer E. Enzyme-linked immunoelectrotransferency blot assay and glycoprotein antigens for diagnosing human cysticercosis. J Infect Dis. 159:1989;50.
83. Ordoñez G., Medina M.T., Sotelo J. Immunoblot analysis of serum and CSF from patients with various forms of neurocysticercosis. Neurol Infect Epidemiol. 1:1996;57.
84. Ramos-Kuri M., Montoya R.M., Padilla A.et al. Immunodiagnosis of neurocysticercosis. disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients Arch Neurol. 49:1992;633.
85. Gevorkian G., Manoutcharian K., Larralde C.et al. Immunodominant synthetic peptides of Taenia crassiceps in murine and human cysticercosis. Immunol Lett. 49:1996;185.
86. García E., Ordóñez G., Sotelo J. Antigens from Taenia crassiceps cysticerci used in complement fixation, enzyme-linked immunosorbent assay, and Western blot (immunoblot) for diagnosis of neurocysticercosis. J Clin Microbiol. 33:1995;3324.
87. Del Brutto O.H., Wadia N.H., Dumas M., Cruz M., Tsang V.C.W., Schantz P.M. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci. 142:1996;1.
88. Del Brutto O.H., Sotelo J., Román G.C. Therapy for neurocysticercosis. a reappraisal Clin Infect Dis. 17:1993;730.
89. Robles C., Chavarría M. Presentación de un caso clínico de cisticercosis cerebral tratado médicamente con un nuevo fármaco. praziquantel Salud Publica Mex. 21:1979;603.
90. Sotelo J., Escobedo F., Rodríguez-Carbajal J., Torres B., Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med. 301:1984;1001.
91. Sotelo J., Torres B., Rubio-Donnadieu F., Escobedo F., Rodríguez-Carbajal J. Praziquantel in the treatment of neurocysticercosis. a long-term follow-up Neurology. 35:1985;752.
92. Escobedo F., Penagos P., Rodríguez J., Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med. 147:1987;738.
93. Sotelo J., Penagos P., Escobedo F., Del Brutto O.H. Short course of albendazole therapy for neurocysticercosis. Arch Neurol. 45:1988;1130.
94. Cruz I., Cruz M.E., Carrasco F., Horton J. Neurocysticercosis. optimal dose treatment with albendazole J Neurol Sci. 133:1995;152.
95. García H.H., Gilman R.H., Horton J.et al. Albendazole therapy for neurocysticercosis. a prospective double-blind trial comparing 7 versus 14 days of treatment Neurology. 48:1997;1421.
96. Sotelo J., Escobedo F., Penagos P. Albendazole vs praziquantel therapy of neurocysticercosis. a controlled trial Arch Neurol. 45:1988;532.
97. Sotelo J., Del Brutto O.H., Penagos P.et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol. 237:1990;69.
98. Takayanagui O.M., Jardim E. Therapy for neurocysticercosis. comparison between albendazole and praziquantel Arch Neurol. 49:1992;290.
99. Cruz M., Cruz I., Horton J. Albendazole vs praziquantel in the treatment of cerebral cysticercosis. clinical evaluation Trans R Soc Trop Med Hyg. 85:1991;244.
100. Del Brutto O.H., Sotelo J., Aguirre R., Díaz-Calderón E., Alarcón T.A. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol. 49:1992;535.
101. Del Brutto O.H. Albendazole therapy for subarachnoid cysticerci. clinical and neuroimaging analysis of 17 patients J Neurol Neurosurg Psychiatry. 62:1997;659.
102. Bittencourt P.R.M., Gracia C.M., Gorz A.M., Mazer S., Oliveira T.V. High-dose praziquantel for neurocysticercosis. efficacy and tolerability Eur Neurol. 30:1990;229.
103. Corona T., Lugo R., Medina R., Sotelo J. Single-day praziquantel therapy for neurocysticercosis. N Engl J Med. 334:1996;125. [Letter].
104. Del Brutto O.H., Campos X., Sánchez J., Mosquera A. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology. In press:1999.
105. Del Brutto O.H. Medical treatment of cysticercosis-effective. Arch Neurol. 52:1995;102.
106. Vázquez V., Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med. 327:1992;696.
107. Medina M.T., Genton P., Montoya M.C., Córdova S., Dravet C., Sotelo J. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis. a pilot trial Epilepsy. 34:1993;1024.
108. Santoyo H., Corona R., Sotelo J. Total recovery of visual function after treatment for cerebral cysticercosis. N Engl J Med. 324:1991;1137. [Letter].
109. Rawlings D., Ferriero D.M., Messing R.O. Early CT evaluation after empirical praziquantel therapy in neurocysticercosis. Neurology. 39:1989;739.
110. Del Brutto O.H. The use of albendazole in patients with single lesions enhanced on contrast CT. N Engl J Med. 328:1993;356. [Letter].
111. Del Brutto O.H., Quintero L.A. Cysticercosis mimicking brain tumor. the role of albendazole as a diagnostic tool Clin Neurol Neurosurg. 97:1995;256.
112. Del Brutto O.H. Clues to prevent cerebrovascular hazards of cysticidal drug therapy. Stroke. 28:1997;1088. [Letter].
113. Del Brutto O.H., Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis. J Neurosurg. 72:1990;816.
114. Del Brutto O.H. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology. 44:1994;1706.
115. Román R.A.S., Soto-Hernández J.L., Sotelo J. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis. a preliminary study J Neurosurg. 84:1996;629.
116. deGhetaldi L.D., Norman R.M., Douville A.W. Jr. Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. Ann Intern Med. 99:1983;179.
117. Colli B.O., Martelli N., Assirati J.A. Jr., Machado H.R., Forjaz S.V. Results of surgical treatment of neurocysticercosis in 69 cases. J Neurosurg. 65:1986;309.
118. Rueda-Franco F. Surgical considerations in neurocysticercosis. Child Nerv Syst. 3:1987;212.
119. Sotelo J., Marín C. Hydrocephalus secondary to cysticercotic arachnoiditis. a long-term follow-up review of 92 cases J Neurosurg. 66:1987;686.
120. Sotelo J. A new ventriculoperitoneal shunt for treatment of hydrocephalus. Experimental results. RBM Eur J Biomed Technol. 15:1993;257.
121. Sotelo J., Rubalcava M.A., Gómez-Llata S. A new shunt for hydrocephalus that relies on CSF production rather than on ventricular pressure. initial clinical experience Surg Neurol. 43:1995;324.
122. Sotelo J. Update. the new ventriculoperitoneal shunt at the Institute of Neurology of Mexico Surg Neurol. 46:1996;19.
123. Apuzzo M.L.J., Dobkin W.R., Zee C.-S., Chan J.C., Giannotta S.L., Weiss M.H. Surgical considerations in treatment of intraventricular cysticercosis. an analysis of 45 cases J Neurosurg. 60:1984;400.
124. Neal J.H. An endoscopic approach to cysticercosis cysts of the posterior third ventricle. Neurosurgery. 36:1995;1040.